A historical sketch of the discovery and development of HIV-1 integrase inhibitors

2006 ◽  
Vol 15 (12) ◽  
pp. 1507-1522 ◽  
Author(s):  
Andrea Savarino
2015 ◽  
Vol 11 (2) ◽  
pp. 180-187 ◽  
Author(s):  
Liming Hu ◽  
Zhipeng Li ◽  
Zhanyang Wang ◽  
Gengxin Liu ◽  
Xianzhuo He ◽  
...  

2020 ◽  
Vol 6 (3) ◽  
pp. 100002
Author(s):  
Pablo Ferrer ◽  
Consuelo Rodriguez ◽  
Alicia Sciaraffia ◽  
Rocío Tordecilla ◽  
Veronica Ramos ◽  
...  

ChemInform ◽  
2007 ◽  
Vol 38 (41) ◽  
Author(s):  
Stefania Ferro ◽  
Maria Letizia Barreca ◽  
Laura De Luca ◽  
Angela Rao ◽  
Anna Maria Monforte ◽  
...  
Keyword(s):  

2014 ◽  
Vol 57 ◽  
pp. 1-4 ◽  
Author(s):  
Temitope O. Olomola ◽  
Salerwe Mosebi ◽  
Rosalyn Klein ◽  
Telisha Traut-Johnstone ◽  
Judy Coates ◽  
...  
Keyword(s):  

2006 ◽  
Vol 49 (5) ◽  
pp. 1506-1508 ◽  
Author(s):  
Motohide Sato ◽  
Takahisa Motomura ◽  
Hisateru Aramaki ◽  
Takashi Matsuda ◽  
Masaki Yamashita ◽  
...  

2009 ◽  
Vol 19 (7) ◽  
pp. 1930-1934 ◽  
Author(s):  
Monica Donghi ◽  
Olaf D. Kinzel ◽  
Vincenzo Summa
Keyword(s):  

2006 ◽  
Vol 14 (11) ◽  
pp. 3785-3792 ◽  
Author(s):  
Jinxia Deng ◽  
James A. Kelley ◽  
Joseph J. Barchi ◽  
Tino Sanchez ◽  
Raveendra Dayam ◽  
...  

2021 ◽  
Vol 17 ◽  
Author(s):  
Nafiseh Karimi ◽  
Rouhollah Vahabpour Roudsari ◽  
Zahra Hajimahdi ◽  
Afshin Zarghi

Background: Integrase enzyme is a validated drug target to discover novel structures as anti-HIV-1 agents. Objective: Novel series of thioimidazolyl diketo acid derivatives characterizing various substituents at N-1 and 2-thio positions of central ring were developed as HIV-1 integrase inhibitors. Results: The obtained molecules were evaluated in the enzyme assay, displaying promising integrase inhibitory activity with IC50 values ranging from 0.9 to 7.7 M. The synthesized compounds were also tested for antiviral activity and cytotoxicity using HeLa cells infected by the single-cycle replicable HIV-1 NL4-3. Conclusion: The most potent compound was 18i with EC50=19 µM, IC50 0.9 µM and SI= 10.5. Docking studies indicated that the binding mode of the active molecule is well aligned with the known HIV-1 integrase inhibitors.


2010 ◽  
Vol 45 (9) ◽  
pp. 3970-3980 ◽  
Author(s):  
Zhengjun Cheng ◽  
Yuntao Zhang ◽  
Weizhong Fu

Sign in / Sign up

Export Citation Format

Share Document